Clifford Chance
Clifford Chance boosts IP team Paid Members Public
The key hire is a boost for Clifford Chance. Here’s what it means for the firm.
Billion Dollar Insurance Deal Paid Members Public
Clifford Chance and Debevoise are heading this insurance deal.
Clifford Chance, Kirkland boost teams Paid Members Public
The key Law Firm hires of the week and what it tells us about their growth strategies!
Salmon Cartel Paid Members Public
Freshfields, Clifford Chance, Cleary and Skadden are advising on this one.
Arsenal and Liverpool settle Insurance claim Paid Members Public
Arsenal FC and Liverpool FC have reached a settlement with their insurers.
Freshfields and Clifford Chance Advise on UCB’s $680 Million Sale Paid Members Public
In Short: Belgian biopharma giant UCB is selling its portfolio of established products in China, including epilepsy drug Keppra and antihistamine Zyrtec, to Singapore's CBC Group and Abu Dhabi’s Mubadala Investment Co. for $680 million. This move allows UCB to focus on developing new medicines in China,
